Sign in
Taking people in United StatesNo phase

Cold and compression for pain after knee replacement surgery in people with knee osteoarthritis

Tests cold and compression for pain after knee replacement in osteoarthritis patients.

Key facts

Who runs it
Ochsner Health System
Where
New Orleans, United StatesSee the site
Trial code
Registry title
Cold and Compression Post TKA
Status
Recruiting
People taking part
90 people, planned
Started
15 Dec 2025
Expected to end
Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cold and Compression
  • SOC (Standard of care)
Record updated
2 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 50 or older with primary osteoarthritis who are scheduled for a total knee replacement at Ochsner Kenner. It compares a cold and compression device with usual cold therapy for pain after surgery.

Age
50 Years or older
Sex
All
Disease stage
Primary osteoarthritis (joint wear) of the knee, with total knee replacement planned by Dr. Howard Hirsch or Dr. Vinod Dasa. People must do all outpatient physical therapy at OTW Driftwood and speak English.
Earlier treatment
People cannot join if they use opioid pain medicines long-term or used opioids in the last 3 months.

Main reasons for not taking part

  • PCS score of 30 or more (a pain-worry questionnaire)
  • Inflammatory diseases such as gout, rheumatoid arthritis or lupus
  • Diabetes, poor blood flow, blood clots (DVT) or pulmonary embolism, heart failure
  • Cold intolerance, cold allergy or Raynaud's
  • Discharge to a skilled nursing facility after surgery

The registry criteria, word for word

Show all 53 criteriaShow less

Who can take part

  • Aged 50 yr or older
  • Patient of Dr. Howard Hirsch or Dr. Vinod Dasa scheduled for total knee arthroplasty (knee replacement) at Ochsner Kenner
  • Will receive outpatient physical therapy at OTW Driftwood for the entire post-op rehabilitation period
  • English speaking
  • Diagnosis of primary osteoarthritis

Who cannot take part

  • Had recent toe surgery in the affected region
  • Areas of skin breakdown or damage (damaged or at-risk skin) producing uneven heat conduction across the skin (e.g., open wound, scar tissue, burn or skin graft). Any open wound must be dressed prior to use of the Polar Care Wave System
  • Diagnosis of inflammatory disease process (i.e., gout, rheumatoid arthritis, systematic lupus erythematosus...)
  • Cold intolerance related to diseases, like Raynaud's
  • Significant vascular impairment in the affected region
  • Significant risk factors or current clinical signs of embolism (e.g., pulmonary embolus, pulmonary edema, cerebral infarction, atrial fibrillation, endocarditis, myocardial infarction, or atheromatous embolic plaque)
  • A condition in which increased venous or lymphatic return is not desired in the affected extremity (e.g., lymphedema after breast cancer or other local carcinoma and/or carcinoma metastasis in the affected extremity)
  • Uncontrolled hypertension (physician discretion), cardiac failure, extreme low blood pressure, or decompensated cardiac insufficiency
  • Localized unstable skin condition (e.g., dermatitis, vein ligation, gangrene, or recent skin graft) in the affected region
  • Current clinical signs in the affected region of significant peripheral edema (e.g., deep vein thrombosis, chronic venous insufficiency, acute compartment syndrome, systemic venous hypertension, congestive heart failure, cirrhosis/liver failure, renal failure)
  • Any active local or systemic infection
  • Obtunded or with diabetes mellitus, multiple sclerosis, poor circulation, spinal cord injuries, and rheumatoid arthritis
  • Presumptive evidence of congestive heart failure
  • Pre-existing DVT condition
  • Deep acute venal thrombosis (Phlebothrombosis)
  • Decompensated cardiac insufficiency
  • Acute inflammatory skin diseases or infection
  • Venous or arterial occlusive disease
  • Severe arteriosclerosis, or active infection
  • Tissues inflamed as a result of recent injury or exacerbation of chronic inflammatory condition
  • Compromised local circulation or neurologic impairment (including paralysis or localized compromise due to multiple surgical procedures or diabetes) in the affected region
  • Cold allergy
  • Cold agglutinin disorders like paroxysmal cold hemoglobinuria
  • Buerger's disease
  • Uncontrolled diabetes (physician discretion)
  • Hypersensitivity to cold
  • History of cold injury
  • Severe cardiovascular disease, anesthetic skin, hypercoagulation disorders, poor circulation, extremities sensitive to pain, extremely low blood pressure that are incapacitated, decreased skin sensitivity, vein ligation or recent skin grafts, or pheochromocytoma
  • Known hematological dyscrasias that predispose to thrombosis (e.g., paroxysmal cold hemoglobinuria, cryoglobulinemia, sicklecell disease, serum cold agglutinins)
  • Chronic opioid use
  • Opioid use within the last 3 months
  • PCS score ≥ 30
  • Discharge to skilled nursing
  • Current clinical signs of inflammatory phlebitis, venous ulcers, or cellulitis
  • An acute, unstable (untreated) fracture in the affected region
  • Episodes of pulmonary embolism
  • Pulmonary edema
  • Acute inflammation of the veins (Thrombophlebitis)
  • Arterial dysregulation
  • Erysipelas
  • Carcinoma and carcinoma metastasis in the affected extremity
  • Decompensated hypertonia
  • Medical situations where increased venous or lymphatic return is undesirable
  • Poor peripheral circulation
  • Cognition or communication impairments that prevent them from giving accurate and timely feedback
  • Chilblains
  • Cryoglobulinemia
  • Sickle cell anemia

Where in United States

  • Ochsner Medical Center - KennerNew Orleans, United StatesContact: Vinod Dasa, MDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to compare pain score (Patient-Reported Outcomes Measurement Information System: PROMIS NRS Pain Subscale) between the control and cold/compression groups pre-surgically, daily after surgery for 14 days, then weekly after surgery for 3 months, and at 6 months post-surgery.

The 2 groups in the trial

  • Standard of Care ArmExisting treatment, for comparison

    Patients in this arm will receive standard therapy post-surgery and discharged with 28 hydrocodone/APAP 7.5 mg pills taken every 6 hours as needed (or its MME equivalent), 1 identical refill if patient calls, and cold therapy (bag of ice or gel pack)

    Treatment: SOC (Standard of care)

  • Cold and CompressionTreatment being tested

    Patients in this arm will be discharged with 28 hydrocodone/APAP 7.5 mg pills taken every 6 hours as needed (or its MME equivalent), 1 identical refill if patient calls, and cold \& compression therapy device provided by Sponsor)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cold and Compression After Total Knee Arthroplasty for Pain Attenuation: A Randomized, Controlled Trial
Plain-language title
Cold and compression for pain after knee replacement surgery in people with knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
2 April 2026